Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Buy
83,500
+2,159
+3% +$770K 3.15% 11
2025
Q4
$26.6M Buy
81,341
+11,143
+16% +$3.53M 2.81% 13
2025
Q3
$19.8M Buy
70,198
+2,509
+4% +$728K 2.25% 18
2025
Q2
$18.9M Buy
67,689
+2,039
+3% +$578K 2.29% 17
2025
Q1
$20.5M Buy
65,650
+8,562
+15% +$2.53M 2.77% 14
2024
Q4
$14.9M Buy
57,088
+4,537
+9% +$1.35M 2.05% 22
2024
Q3
$16.9M Buy
52,551
+8,482
+19% +$2.77M 2.38% 20
2024
Q2
$13.8M Buy
44,069
+6,170
+16% +$1.81M 2.23% 25
2024
Q1
$10.8M Buy
+37,899
New +$11.1M 1.82% 28

Other funds holding AMGN

Tamar Securities's AMGN Position: Q1 2026 in Review

Tamar Securities increased its Amgen (AMGN) stake by 2.7% in Q1 2026, buying an estimated $770K and bringing the position to 83,500 shares worth $29.4M. The position accounts for 3.15% of the portfolio, ranked #11.

Tamar Securities first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tamar Securities held 83,500 shares of Amgen worth $29.4M as of Q1 2026.
  • Tamar Securities bought 2,159 Amgen shares in Q1 2026, an estimated $770K.
  • Amgen made up 3.15% of Tamar Securities's portfolio in Q1 2026, its #11 holding.
  • Tamar Securities first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tamar Securities's 13F filing for Q1 2026, filed 14 May 2026.